#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchiectasis Metabolic disorder Non-renal cell carcinoma of kidney Glomerulonephritis chronic Pancreatic carcinoma Congenital disorder of glycosylation Leber's congenital amaurosis Undifferentiated sarcoma Autologous haematopoietic stem cell transplant Urea cycle disorder Lymphangiosarcoma Brain abscess Renal cell carcinoma Stargardt's disease Scleroderma associated digital ulcer More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease – Trials in Disease Osteosarcoma – Diagnostics Loeys-Dietz syndrome – Life with Disease Biotinidase deficiency – Basic Information Factor IX deficiency SAPHO syndrome Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Krabbe’s disease – Life with Disease Advanced systemic mastocytosis Retinoblastoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carbasalate Calcium Afatinib Tuvusertib Human Serum Albumin Mercaptopurine Monohydrate Sodium Valproate Fosinopril Sodium Luspatercept Syn321 89ZR-CED88004S Bhv-7000 Ergocalciferol Nmd670 Azelastine VENT-03 Emapalumab Ht-29-A Mps-200 Azd0305 BI 456906 More therapies…

    Learn about Your Condition

    Postoperative delirium Immune-mediated enterocolitis Haemodynamic instability Tooth loss Staphylococcal bacteraemia Colon cancer metastatic Albuminuria Hepatic cirrhosis Hepatic adenoma Meningioma malignant Ovarian cancer stage IV Juvenile spondyloarthritis Ulcerative keratitis Psychogenic seizure Hyperadrenocorticism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Male Urogenital Diseases

  • Study of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Masofaniten
    • Enzalutamide
    Belgium France Spain

  • Study of BI 764198 for Patients with Focal Segmental Glomerulosclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Focal segmental glomerulosclerosis
    Investigated Drugs:
    • [4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
    Belgium France Germany Italy Spain

  • Study on Denosumab for Improving Semen Quality in Men with Non-Obstructive Azoospermia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Infertility male
    Investigated Drugs:
    • Letrozole
    • Denosumab
    Denmark

  • Study on Prostate Cancer Treatment: Comparing Goserelin Acetate, Leuprorelin Acetate, Degarelix, and Apalutamide in Patients with Biochemical Progression After Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Triptorelin
    • Degarelix
    • Leuprorelin Acetate
    Belgium

  • Study on Stereotactic Body Radiation Therapy with or without Durvalumab for Patients with Oligometastatic Hormone-Sensitive Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Durvalumab
    France

  • Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End-Stage Kidney Disease on Hemodialysis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hyperparathyroidism secondary
    Investigated Drugs:
    • Upacicalcet Sodium Hydrate
    Bulgaria Poland Portugal Spain
Previous Page
1 … 19 20 21 22 23 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!